Publications by authors named "Bertuzzi C"

Background: Classical Hodgkin's lymphoma (cHL) in adolescents between 15 and 18 years old shows a higher disease-related mortality, and the overall prognosis is worse than in both children and adults.

Objectives: We investigated the immune checkpoint inhibitors (ICPIs) therapeutic targets and specific T-regulatory and cytotoxic T-cell subsets in the subgroup of adolescent cHL patients, and we challenged their prognostic power.

Methods: We retrieved formalin-fixed paraffin-embedded (FFPE) tissue of adolescent patients diagnosed with cHL and tested by immunohistochemistry the immune checkpoint molecules CTLA-4, LAG-3, PD-1, and PDL1 as well as the biological markers FOXP3 and CD8.

View Article and Find Full Text PDF
Article Synopsis
  • Follicular Lymphoma (FL) often leads to cycles of remission and relapse, making it nearly incurable, and current prognostic scores don't work well for all patients.
  • This study analyzed 49 FL lymph node biopsies to explore the relationship between immune cell types in the tumor microenvironment and patient outcomes, focusing on specific markers like CD56 and CD163.
  • Results indicated that certain ratios of immune cells were linked to survival rates, suggesting enhancing macrophage characterization could improve prognosis for FL patients, but further research is needed.
View Article and Find Full Text PDF

Extranodal T-lymphoproliferative disorders or T-cell lymphomas (TLPD) are classified according to the WHO Classification (4th and upcoming 5th editions) (Swerdlow et al., IARC Press 1; Alaggio et al., Leukemia 36(7):1720-1748, 2) and to the International Consensus Classification Update (Campo et al.

View Article and Find Full Text PDF
Article Synopsis
  • - The text discusses CAR-T cell therapy's efficacy against CD19 in treating neoplastic B cells, highlighting limitations such as target antigen loss and T cell exhaustion, which can hinder treatment success.
  • - A case study is presented of a patient with refractory Diffuse Large B-cell Lymphoma who did not respond to CAR-T therapy or subsequent pembrolizumab treatment, but achieved remission after being treated with Brentuximab-Vedotin.
  • - The study concludes that pembrolizumab cannot revive exhausted CAR T cells and suggests that their senescent state, along with changes in non-CAR T cells, create a less effective immune environment against the tumor.
View Article and Find Full Text PDF

Mycosis fungoides (MF) and Sezary syndrome (SS) are the two most common type of cutaneous T-cell lymphoma (CTCL). Currently, no markers can be clearly related to prognosis or to differential diagnosis between early stages and inflammatory benign diseases (IBD). The thymocyte selection-associated high mobility group box factor (TOX), has been proposed as a possible marker in differential diagnosis between early CTCL stages and IBD.

View Article and Find Full Text PDF
Article Synopsis
  • - Hepatocellular carcinoma (HCC) has a low mutation rate and fewer tumor-infiltrating lymphocytes (TILs), complicating the search for targeted therapies, prompting this study on the role of TILs in HCC prognosis.
  • - The research involved 41 patients who underwent liver resection, revealing that HCCs with solid architecture had increased CD8+ TILs but a higher PD-1/TIA1 ratio, indicating less functional lymphocytes in these tumors.
  • - Analysis showed that a higher TIA1/CD8 ratio correlated with tumor recurrence, suggesting that more activated TILs indicate greater tumor aggressiveness, and a simple immunohistochemical panel could aid in post-surgical prognosis
View Article and Find Full Text PDF
Article Synopsis
  • Myeloid sarcoma (MS) is a type of solid leukemia characterized by the proliferation of myeloid blasts, often occurring in patients with prior blood disorders or post-bone marrow transplant.
  • A case study highlighted an MS tumor in the breast of a woman with JAK2-mutated essential thrombocythemia, which initially resembled lobular breast carcinoma but was differentiated through immunohistochemical analysis.
  • The diagnosis was unique, as it was the first reported case of MS of the breast in someone with essential thrombocythemia, and the tumor later relapsed in the pelvic region, prompting a review of related literature from the past decade.
View Article and Find Full Text PDF

Whole grains are a pivotal food category for the human diet and represent an invaluable source of carbohydrates, proteins, fibers, phytocompunds, minerals, and vitamins. Many studies have shown that the consumption of whole grains is linked to a reduced risk of cancer, cardiovascular diseases, and type 2 diabetes and other chronic diseases. However, several of their positive health effects seem to disappear when grains are consumed in the refined form.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how myeloid nuclear differentiation antigen (MNDA) expression can aid in differentiating lymphoplasmacytic lymphoma (LPL) from splenic marginal zone B-cell lymphoma (SMZL) since their characteristics often overlap.
  • It was found that while the MYD88 p.Leu265Pro mutation was identified in some LPL cases, MNDA was predominantly negative in these cases, indicating it could help rule out LPL.
  • MNDA expression was more frequent in SMZL cases, and additional specific immunohistochemical features correlated with MNDA positivity, suggesting its usefulness in diagnosing SMZL when genetic mutation tests are not available.
View Article and Find Full Text PDF

Progression in Ph-chromosome-negative myeloproliferative neoplasms (MPN) develops with variable incidence and time sequence in essential thrombocythemia, polycythemia vera, and primary myelofibrosis. These diseases show different clinic-pathologic features and outcomes despite sharing deregulated JAK/STAT signaling due to mutations in either the Janus kinase 2 or myeloproliferative leukemia or eticulin genes, which are the primary drivers of the diseases, as well as defined diagnostic criteria and biomarkers in most cases. Progression is defined by the development or worsening of marrow fibrosis or the progressive increase in the marrow blast percentage.

View Article and Find Full Text PDF

Classical Hodgkin's lymphoma (cHL) accounts for 10% of all lymphoma diagnosis. The peculiar feature of the disease is the presence of large multinucleated Reed-Sternberg and mononuclear Hodgkin cells interspersed with a reactive microenvironment (ME). Due to the production of a large number of cytokines, Hodgkin cells (HCs) and Hodgkin Reed-Sternberg cells (HRSCs) attract and favour the expansion of different immune cell populations, modifying their functional status in order to receive prosurvival stimuli and to turn off the antitumour immune response.

View Article and Find Full Text PDF

Many diseases can induce splenomegaly, however, about 5% of splenomegalies are idiopathic. When there is no underlying treatable cause, and the splenomegaly significantly affects the quality of life, splenectomy is the best therapeutic choice. A 67-year-old woman had idiopathic and asymptomatic splenomegaly.

View Article and Find Full Text PDF

Mycosis fungoides (MF) represents the most common type of cutaneous lymphoma. In the majority of patients, the disease has a slow evolution and a protracted course; however, a subset of patients shows poor oncologic outcomes. Unfortunately, there are no reliable prognostic markers for MF, and the currently available treatments are only effective in a minority of patients.

View Article and Find Full Text PDF

Bcl-2 family protein plays an important role in apoptosis and its overexpression is protects neoplastic cell from apoptotic stimuli. Cutaneous B-cell lymphoma are rare non-Hodgkin lymphomas and can be classified in primary forms, featuring an exclusive skin-involvement at diagnosis, and cutaneous spread of a nodal disease. Such a distinction is not trivial, owing to different prognosis (indolent vs.

View Article and Find Full Text PDF
Article Synopsis
  • Ibrutinib is a medication used to treat certain blood cancers and can cause skin-related side effects (SAE) in patients.
  • A study identified 25 patients who experienced cutaneous SAE, with common issues including hair and nail problems, eczematous reactions, and a specific type of inflammation (leucocytoclastic vasculitis).
  • Despite these skin-related issues, patients continued their treatment without additional adverse effects, indicating that it's important to monitor and manage skin reactions associated with Ibrutinib use.
View Article and Find Full Text PDF